Open Innovation and your Intellectual Property Rights

Open Innovation and your Intellectual Property Rights

Recently, growing attention has been devoted to the concept of “Open Innovation”, both in academia as well as in industry. We cover what Open Innovation is and what it means for you and your intellectual property rights.


What is Open Innovation?

Open Innovation is the development of innovative solutions made on the basis of collaboration between a number of parties. It has the advantages of shortening the time to innovate, sharing risks, and reducing costs. Open Innovation offers a different model to the historical closed model where the entire innovative process is carried out internally by companies, often in secret.

There have been misconceptions that Open Innovation and owning Intellectual Property Rights are mutually exclusive, when in reality they positively complement each other. Open Innovation is a term used to promote innovating with collaborators by “sharing risk and sharing reward” - the problem is caused by what the term “sharing” means.

An example of headline “Open Innovation” initiatives is when Tesla™ decided to open up their patent portfolio to the world - the move has been subject of much debate. It can be argued that they have given away their greatest competitive advantage or alternatively, it can be argued that they have shortened their innovation cycle by removing the disclosure stage of discussions with potential collaborators; the truth probably lies somewhere in between.


Comparison of Open and Closed Innovation

Open Innovation Principles

Closed Innovation Principles

Building a better business model is better than being first to market.

First to market an innovation is a commercial advantage.

Having the ability to use the best of internal and external ideas.

Can keep the best ideas internally and secret.

Knowledge and expertise in an area is dispersed and must be brought together to succeed.

Consolidating knowledge in one place is strategically important.

External R&D has significant value: internal cooperative R&D can claim a share of that value.

Control of the complete R&D from discovery, development, to commercialisation.

Unburdened from requirement to originate the research in order to profit from it.

Originating discoveries allows control of the market.

Everyone should benefit from all innovations whenever it advances in a business model.

Control of intellectual property (IP) so that  competitors can not profit from ideas

IP and Open Innovation

In the context of Open Innovation, intellectual property plays a new role which no longer reflects the historical defensive mechanism adopted by companies.

For example, to-date companies have been using their patents to block competitors and to  operate on the market based on the notion of a patent as a negative right to exclude others rather than to enable innovation. Yet, on the contrary, patent protection assists companies to commercialise their solutions and safely enter into Open Innovation agreements, with limited risks of seeing their assets appropriated by their collaborators. Indeed, patents are extremely important for the innovative process since they protect and disclose at the same time.

Open Innovation is facilitated by effective intellectual property protection. Clear ownership helps in sharing of knowledge, as collaborators are more willing to enter into transactions and agreements to exchange their inventions.

Strong intellectual property strategies are of utmost importance for small entities with very specific R&D capabilities and which require larger entities to commercialize their products. They would fail to attract collaborators and investors if lacking a robust intellectual property strategy.

Because of the nature of Open Innovation, efficient intellectual property management is essential for the success of the project. Sharing knowledge, technology and expertise between collaborators is an enormous benefit that could nevertheless entail a risk of loss of such assets and free-riding, if not managed effectively. Accordingly, a co-development of activities carried out in an Open Innovation environment requires a clear agreement on ownership of any resultant IP, particularly where parties to the development have no previously registered IP in the relevant activity.


Are you considering entering into Open Innovation?

Questions you should ask yourself:

  • What will happen to my concept?
  • How can I protect my products if I do not fully own the IP rights?
  • How can I protect my trade secrets and know-how from being lost within such a process?
  • What is happening to my position in the long run by sharing or licencing my IP rights?

If you are considering engaging in Open Innovation, you will need to assess the impact of your decisions now and in the future. Such arrangements can be very rewarding, but, you should also remember to protect yourself.


Need advice on your Intellectual Property Rights and Open Innovation?

Related News


Coronavirus - UK IPO, EPO and EU IPO extensions and support

A simple overview of the current status from IPOs. Last updated 31st March 2020. 

EPO announces extensions to deadlines due to COVID-19

EPO announces extensions to deadlines due to COVID-19

On Sunday 15 March 2020 the EPO published a notice advising it is invoking the provisions of Rule 134(2) EPC, and has extended all periods expiring on or after publication of the notice to 17 April 2020. This may be extended by the EPO upon publication of a further notice.

EUIPO extends all deadlines for Community Design and European Union Trade Marks

EUIPO extends all deadlines for Community Design and European Union Trade Marks

The Executive Director of the EUIPO has today (16 March 2020) issued a decision regarding extensions for all time limits on trade mark and design matters at the EUIPO. In accordance with the decision, all time limits expiring between 9 March 2020 and 30 April 2020 inclusive are extended until 1 May 2020.


UK IPO announces support for those affected by coronavirus

In brief, the UK IPO has indicated that it will use its discretionary powers (on a case-by-case basis) to extend time limits where possible under national and international law.

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”

Earlier this year, we reported on the EPO Board of Appeal’s decision to uphold the revocation of the Broad Institute’s CRISPR patent (here). Now it appears that the Broad Institute is gearing up to put forward a petition for review by the Enlarged Board of Appeal as a last resort to save their patent.


The UPC is dead, long live the UPC!

European patent attorneys have been getting excited about the Unitary Patent (UP) and Unified Patent Court (UPC) for years, writing articles, and giving talks and presentations about the ins-and-outs and twists-and-turns of the whole thing. So what is the current situation? What has happened now?

UPDATE - UK IPO support for those affected by Coronavirus

UPDATE - UK IPO support for those affected by Coronavirus

The UKIPO has now certified that a ‘period of interruption’ began on Tuesday 24 March 2020.

aipex logo aipex logo aipex logo